I am not rebutting you mijo, but the article.
Except depression by definition is not exactly homeostasis. I came away with the impression that they thought depression itself was an evolved beneficial trait, which means it would benefit reproduction.
then there are strange statements about how ADs decrease coping skills, when efficacy of coping skills is improved by ADs in moderate to severe depression.
-There are also strange statements about the increased relapse of depression in the use of ADs, and I have to check again, but I am not sure about what the control group was.
here we go
"An alternate view is that current diagnostic criteria do not accurately distinguish between true instances of disorder and normal, evolved emotional responses to stressors (Wakefield, 1992, 1999; Watson and Andrews, 2002; Hagen, 2003; Horwitz and Wakefield, 2007; Andrews and Thomson Jr., 2009; Andrews et al., 2011). This latter view suggests that the pharmacological disruption of depressive symptoms could negatively affect the ability to cope with or manage stressors."
Nope, in response to stressors the individual may already have depression, and there is no mention of what happens and how long if it is untreated.
How is being vegetative beneficial to the individual, or having severe insomnia?
More strange reasoning unsupported by actual evidence:
"So, while we had difficulty finding strong evidence of beneficial effects, it is possible that antidepressants have a significant beneficial effect not yet identified."
"Patients should be informed that current research suggests that unless they have very severe depression, the symptom reducing effects of antidepressants are modest and are not considered clinically significant. "
Which just shows they don't know about the scaling. The Hamilton Depression Rating Scale I believe has a built in cap on the score, which has a strange effect, there is also only a two or three point difference between severe insomnia and no insomnia. Depending on the type of insomnia, you could have a score from 0-6 depending. So a major reduction in insomnia may show only a shift of a point or two.
http://healthnet.umassmed.edu/mhealth/HAMD.pdf
"Two other things about the HDRS are noteworthy. First, patients with a score of 13 or higher typically meet formal diagnostic criteria for an episode of MDD (Bagby et al., 2004). In other words, many people who meet diagnostic criteria for MDD only have mild/moderate symptoms according to NICE guidelines."
You can get a score of 14 for having insomnia, attempted suicide and being unable to work. So some caution should be taken in what the paper says.
So again we have the same issue as in Talking to Prozac, where a scale meant to assess really only the presence or absence of depression is used to support what should be assessed on a finer scale.
Both pharma and the critics are wrong for using such scales. Again a major part of teh problem is pharma and researchers using the BDI and the HDRS to assess symptom response. (The BDI is worse for that)
We could easily go through the HDRS and make an individual who has a score that varies by only seven points and still has major improvement in their functioning. Especially since the HDRS has a built in cap